BERGEM·HEALTH
Home › Treatments › Gastroenterology
Gastroenterology
SPECIALITY · GASTROENTEROLOGY

Gastroenterology in Türkiye — hepatitis C cure, IBD biologics, advanced endoscopy

Direct-acting antivirals for HCV (SVR12 >95%), biologic therapy for Crohn’s/UC, therapeutic endoscopy (ESD, EUS, ERCP), hepatology with transplant pathway.

What you get
  • Written second opinion on endoscopy, biopsy, FibroScan in 48 hours
  • Hepatitis C cure with DAA — 8–12 week courses, SVR12 >95%
  • IBD pathway: infusion centre, fast-track flare protocols
  • End-stage liver disease referred to organ-transplant team
5 hospitals · 9 GI professors · DAA · ESD · EUS-FNA · FibroScan
SECOND OPINION ONLINE

Second opinion from a GI/hepatology professor — within 48 hours, free

Send your endoscopy report, biopsy, FibroScan, viral load or recent imaging — the professor returns a written second opinion within 48 hours, free of charge.

01
Upload your discharge summary
Discharge summaries, CT/MRI discs (DICOM), histology slides if available. Up to 200 MB.
02
Coordinator reviews
Selects 2–3 professors matched to your diagnosis and stage. Sends them your records.
03
Video consultation
The professor responds online — review of histology, protocol, travel plan if needed.
What to send
  • Discharge summaries from inpatient / outpatient care
  • CT or MRI — original DICOM discs
  • Histology report (if available)
  • Slides or blocks for review (optional)
  • Current therapy list
Request a second opinion
Free. Confidential. Anna Moroz reads every request personally.
10 PROCEDURES

What we treat in gastroenterology

Liver disease, IBD, oncology workup and advanced endoscopy at our partner hospitals in Istanbul and Antalya.

TREATMENT METHODS

Treatment methods in gastroenterology

DAA antivirals, biologics, advanced therapeutic endoscopy (ESD/EUS/ERCP), interventional radiology for portal hypertension.

Direct-acting antivirals (DAA) for HCV
Sofosbuvir/velpatasvir, glecaprevir/pibrentasvir. 8–12 week courses.
5 clinics
Biologic therapy for IBD
Infusion centre for infliximab and vedolizumab; oral JAK inhibitors where indicated.
4 clinics
Endoscopic Submucosal Dissection (ESD)
Curative resection of early GI cancer.
3 clinics
Endoscopic Ultrasound (EUS)
Diagnostic + therapeutic — EUS-FNA, EUS-BD.
3 clinics
ERCP
Bile and pancreatic duct intervention, stenting.
4 clinics
Radiofrequency ablation of Barrett’s
Endoscopic dysplasia eradication.
2 clinics
TIPS
Transjugular intrahepatic portosystemic shunt.
2 clinics
Bariatric endoscopy
ESG, intragastric balloon for selected patients.
3 clinics
GASTROENTEROLOGY · TEAM

Professors you get direct access to

Professors and senior specialists at Memorial, Liv and Akdeniz. Direct contact, no middlemen.

KP
Prof. Dr. Kamil Yalçın Polat
Chair of the Organ Transplant Centre, Memorial Bahçelievler Hospital; head of the transplant and general surgery centre at Memorial Ataşehir
Memorial Bahçelievler Hospital
Prof. Dr. Dinç Dinçer
Prof. Dr. Dinç Dinçer
Professor of Gastroenterology, Division of Gastroenterology, Department of Internal Medicine; Head of the Gastroenterology Division 2007–2010
Akdeniz University Hospital
BY
Prof. Dr. Bülent Yıldırım
Gastroenterologist; formerly head of the gastroenterology division, Akdeniz University Faculty of Medicine
Memorial Antalya Hospital
Doç. Dr. Süleyman Günay
Doç. Dr. Süleyman Günay
Associate Professor of Gastroenterology
Memorial Göztepe Hospital
Prof. Dr. Aslı Çifcibaşı Örmeci
Prof. Dr. Aslı Çifcibaşı Örmeci
Professor of Gastroenterology
Memorial Göztepe Hospital
Prof. Dr. Eylem Karatay, MD
Prof. Dr. Eylem Karatay, MD
Professor of Gastroenterology
Liv Hospital Vadistanbul
Prof. Dr. Erdem Koçak, MD
Prof. Dr. Erdem Koçak, MD
Professor of Gastroenterology
Liv Hospital Vadistanbul
Prof. Dr. İrfan Koruk, MD
Prof. Dr. İrfan Koruk, MD
Professor of Gastroenterology
Liv Hospital Ulus
Prof. Dr. Binnur Pınarbaşı, MD
Prof. Dr. Binnur Pınarbaşı, MD
Professor of Gastroenterology
Liv Hospital Ulus
Prof. MD. Altay Kandemir
Prof. MD. Altay Kandemir
Professor of Gastroenterology
Liv Hospital Ulus
Prof. Dr. Yusuf Ziya Erzin, MD
Prof. Dr. Yusuf Ziya Erzin, MD
Professor of Gastroenterology
Memorial Bahçelievler Hospital | Istanbul University-Cerrahpaşa
Prof. Dr. Salih Boğa, MD
Prof. Dr. Salih Boğa, MD
Professor of Gastroenterology and Hepatology
Memorial Bahçelievler Hospital
Prof. Dr. A. Emre Yıldırım, MD
Prof. Dr. A. Emre Yıldırım, MD
Professor of Gastroenterology and Hepatology
Memorial Bahçelievler Hospital
Prof. Dr. Abdullah Kısaoğlu, MD
Prof. Dr. Abdullah Kısaoğlu, MD
Professor of General Surgery
Akdeniz University Hospital
Prof. Dr. Gülsüm Özlem Elpek, MD
Prof. Dr. Gülsüm Özlem Elpek, MD
Professor of Pathology
Akdeniz University Hospital
DIAGNOSTICS

GI diagnostics

Gastroscopy, colonoscopy, EUS, FibroScan, viral load, MRI — completed within 1–3 days at a single hospital.

Gastroscopy (EGD)
Upper GI inspection with biopsy.
30 min
Colonoscopy with chromoendoscopy
Polyp detection and biopsy.
45 min
Endoscopic ultrasound (EUS)
Pancreatic, biliary, gastric staging.
1 hour
FibroScan (transient elastography)
Non-invasive liver fibrosis assessment.
15 min
Liver MRI 3T with hepatospecific contrast
HCC characterisation.
1 day
24-hour pH impedance
GERD diagnosis.
24 h
Hydrogen breath test
SIBO, lactose, fructose intolerance.
3 hours
HCV/HBV viral load + genotype
Confirms eligibility for therapy.
1 day
PRICE SNAPSHOT

GI procedures pricing — Türkiye vs EU/USA

Minimum prices, for reference only. The final cost is calculated individually after the doctors review your records.

Procedure Türkiye EU / USA Savings
Hepatitis C cure (12-week DAA) from $3 500 $20 000 – 60 000 −85%
Colonoscopy + biopsy from $400 $2 000 – 4 000 −80%
Gastroscopy + biopsy from $300 $1 500 – 3 000 −80%
ESD (early GI cancer) from $4 500 $20 000 – 40 000 −75%
ERCP with stenting from $3 000 $10 000 – 22 000 −70%
Biologic infusion (per infliximab cycle) from $800 $3 000 – 6 000 −70%
TIPS from $9 000 $30 000 – 55 000 −70%
FibroScan from $80 $300 – 600 −70%
The information on this page is for reference only and does not constitute a medical opinion.
Request a precise quote for my case
QUESTIONS

Frequently asked about Gastroenterology

Can hepatitis C really be cured?
Yes — SVR12 (sustained virological response at 12 weeks) exceeds 95% with modern DAA regimens. Course length depends on the regimen and history: glecaprevir/pibrentasvir is usually 8 weeks for treatment-naïve patients (including compensated cirrhosis), sofosbuvir/velpatasvir 12 weeks; longer or modified courses apply after previous treatment failure or with decompensated cirrhosis. We monitor virological response after treatment.
IBD: when do I need biologics?
Moderate-to-severe disease, steroid-dependent or steroid-refractory, or extensive disease at diagnosis. Anti-TNF (infliximab/adalimumab) is a common first choice and is preferred when there are extra-intestinal manifestations; vedolizumab, ustekinumab or JAK inhibitors are alternatives depending on disease and risk profile.
Early stomach cancer — surgery or ESD?
If T1a (mucosal), well-differentiated, <2 cm and without ulceration — ESD is curative and avoids gastrectomy. Multidisciplinary team confirms staging.
Liver transplant — when is it considered?
MELD ≥15, decompensation, or HCC within Milan criteria. We refer to our hepatobiliary and transplant surgery team — see Organ transplantation.
Am I a candidate for endoscopic submucosal dissection (ESD) for early colorectal cancer?
ESD is considered for early colorectal lesions — typically larger than 20 mm or with features suggesting superficial invasion — that cannot be removed in one piece by standard EMR, after assessment with magnifying NBI and, where needed, EUS. Final histology decides whether the resection is curative. Follow-up colonoscopy is scheduled according to the pathology result.
Should I have capsule endoscopy or colonoscopy for suspected IBD or obscure GI bleeding?
Colonoscopy with ileoscopy and biopsies remains first-line for diagnosing Crohn's or ulcerative colitis. Capsule endoscopy (PillCam SB3) is added when small-bowel disease or obscure bleeding is suspected after negative upper/lower scopes, with diagnostic yield around 60-70%. A patency capsule is used first if stricture risk exists, and findings are correlated by an MDT within 7-10 days.
How is NAFLD/MASLD diagnosed and treated in 2026?
Diagnosis combines liver enzymes, FIB-4, and FibroScan (CAP for steatosis, kPa for fibrosis); biopsy is reserved for indeterminate F2-F3 cases. First-line treatment is 7-10% weight loss. For non-cirrhotic MASH with moderate-to-advanced (F2-F3) fibrosis, two drugs are FDA-approved: resmetirom (Rezdiffra, March 2024) and semaglutide 2.4 mg (Wegovy, August 2025); availability in Türkiye is confirmed individually. Patients are reassessed at 3 and 6 months by a hepatology MDT.
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours